result expect report result
morn revenu y/i y/i
ex-fx came estim
consensu revenu ep guidanc provid
manag anticip similar perform
also partial sell day impact
estim headwind overal deliv day-
adjust ex-fx organ growth y/i ahead
estim y/i level report y/i
stack two-year basi zbh growth acceler
rel sequenti quarter report adjust ep
y/i came estim
commentari earn call schedul et
today dial passcod
provid
outlook rais make progress
turnaround believ achiev goal deliv
ex-fx revenu growth in-lin weight averag market
growth rate wamgr begin six
month earlier previous anticip manag
rais outlook well look
report revenu growth rang flat impli
revenu fx expect
headwind prior headwind would translat top-
line underli growth ep expect
y/i compani ex-fx growth outlook impli
rang versu deliv note
sell day headwind impact
expect revers mostli net impact neutral
year zbh outlook compar current estim
repres underli growth ep
repres growth street look
ep respect elsewher manag
expect oper margin
prior outlook top-end reflect higher business-
relat invest manag expect tax save
remaind plan re-invest busi
expect compani discuss detail earn
call morn
continu page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
ep exclud amort non-recur item
compani data secur llc estim reuter
continu previou page
segment result stack follow sale growth repres y/i ex-fx
rate adjust impact sell day estim sell day
neg impact growth approxim segment zbh
result stack follow
knee sale versu compar estim
result driven sequenti acceler america
europ middl east africa emea off-set deceler asiapacif knee price
slightli wors sequenti versu volum improv
versu zbh knee busi improv sequenti compani begin
benefit full portfolio knee product persona famili knee rosa tka
hip sale versu compar estim
result driven sequenti deceler asiapacif
emea off-set improv america hip price also wors sequenti
versu volum lower well versu
provid color call includ impact competit mako pull
hip launch syk acetabular cup
sport medicin extrem trauma set sale versu
compar estim set price slightli better sequenti
versu volum improv versu
appear improv execut segment challeng past
like benefit improv suppli level
spine craniomaxillofaci cmf sale versu
compar estim spine cmf price versu
volum versu look color call
like result continu impact sale forc integr dis-
synergi spine off-set benefit uptak cmf thorac product
dental sale versu compar estim
dental price versu volum versu
result sequenti improv work new
market strategi within dental busi appear make progress driven portfolio
realign sale reorgan certain geographi
question call focus commentari around zbh abil pace top-lin
growth beyond growth like back-end load given time full launch
key portfolio product persona famili rosa sidu stemless shoulder sell day fx
addit outlook look commentari follow topic zb strategi
offenc initi feedback rosa user zb abil re-captur share suppli
includ rosa expect constrain initi month post launch pace
recoveri growth statu updat fda warn letter time driver
oper leverag portfolio manag
price target nc
price target base approxim cash ep estim risk thesi
includ increas invest slower procedur volum growth price pressur disrupt
integr biomet
zimmer biomet share trade roughli discount large-cap med-tech peer group believ
discount narrow compani benefit leadership new commercially-driven
ceo bryan hanson oper issu resolv pipelin begin fulli
warsaw indiana-bas zimmer biomet hold one world largest orthoped implant
manufactur compani global market leader billion reconstruct orthoped
implant busi hip knee implant togeth account roughli revenu
compani report sale billion
